Skip to main content

Table 7 Analysis of maximum likelihood estimates under Cox's model.

From: Inhibitors of apoptosis proteins in human cervical cancer

Factor Hazard ratio (95% CI) p
(A) Univariate analysis of disease-free survival
FIGO stage 2.41 (1.10–5.00) 0.018
Age 1.00 (0.97–1.00) 0.075
Menopause 0.77 (0.46–1.31) 0.063
Histology 2.58 (1.24–5.41) 0.011
Survivin 0.99 (0.99–1.00) 0.295
Survivin2B 1.00 (0.99–1.01) 0.592
SurvivinΔEx3 1.00 (0.99–1.02) 0.187
XIAP 0.69 (0.59–0.94) 0.048
c-IAP1 0.99 (0.98–1.01) 0.334
c-IAP2 0.98 (0.96–1.00) 0.115
(B) Multivariate Cox model of disease-free survival
FIGO stage 3.13 (1.11–8.81) 0.031
Age 1.06 (0.98–1.13) 0.108
Menopause 0.29 (0.07–1.20) 0.089
Histology 1.77 (0.71–4.41) 0.071
Survivin 0.97 (0.99–1.00) 0.374
Survivin2B 1.00 (0.07–1.03) 0.743
SurvivinΔEx3 0.99 (0.07–1.02) 0.882
XIAP 0.79 (0.69–0.96) 0.516
c-IAP1 0.99 (0.97–1.01) 0.548
c-IAP2 0.99 (0.98–1.00) 0.486